Drugs that contain Fluocinonide
1. Vanos patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6765001 | BAUSCH | Compositions and methods for enhancing corticosteroid delivery |
Dec, 2021
(2 years ago) | |
| US7794738 | BAUSCH | Compositions and methods for enhancing corticosteroid delivery |
Sep, 2022
(1 year, 7 months ago) | |
| US7220424 | BAUSCH | Compositions and methods for enhancing corticosteroid delivery |
Jan, 2023
(1 year, 3 months ago) | |
| US8232264 | BAUSCH | Compositions and methods for enhancing corticosteroid delivery |
Mar, 2023
(1 year, 1 month ago) | |
Market Authorisation Date: 11 February, 2005
Treatment: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older
Dosage: CREAM;TOPICAL
How can I launch a generic of VANOS before it's drug patent expiration?
More Information on Dosage
VANOS family patents
